Catherine L Callahan1, Jonathan N Hofmann1, Douglas A Corley2, Wei K Zhao2, Brian Shuch3, Wong-Ho Chow4, Mark P Purdue5. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States. 2. Division of Research, Kaiser Permanente Northern California, Oakland, California, United States. 3. Department of Urology, Yale School of Medicine, New Haven, Connecticut, United States. 4. Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States. 5. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States. Electronic address: purduem@mail.nih.gov.
Abstract
BACKGROUND: Although obesity is an established risk factor for renal cell carcinoma (RCC), it is unclear whether this relationship varies across histologic subtypes. METHODS: We conducted a nested case-control study within the Kaiser Permanente Northern California (KPNC) health care network, and meta-analysis combining our results with those of previously published studies. Our KPNC study included 685 RCC cases [421 clear cell; 65 papillary; 24 chromophobe; 35 other; 141 not otherwise specified (NOS)] and 4266 controls. Subtype-specific odds ratios (ORs) and 95% confidence intervals (CIs) for categories of body mass index (BMI) and were computed from the case-control data using polytomous logistic regression. Findings from this and other relevant studies were combined by meta-analysis using a random effects model. RESULTS: In the KPNC study, obesity (BMI ≥ 30 kg/m2) was associated with clear cell RCC (OR 1.5, 95% CI 1.1-2.1) and chromophobe RCC (OR 2.5, 95%CI 0.8-8.1), but not with papillary RCC (OR 1.0, 95% CI 0.5-1.9). In meta-analysis including three additional studies, a similar pattern of summary relative risks (SRR) for obesity was observed across subtypes (clear cell: SRR 1.8, 95% CI 1.5-2.2; chromophobe: SRR 2.2, 95% CI 1.3-3.7; papillary, SRR 1.2, 95% CI 0.8-1.6). CONCLUSIONS: These findings support the hypothesis that histologic subtypes of RCC possess distinct etiologic pathways, with obesity important for the development of clear cell and, possibly, chromophobe RCC, but not papillary RCC. Published by Elsevier Ltd.
BACKGROUND: Although obesity is an established risk factor for renal cell carcinoma (RCC), it is unclear whether this relationship varies across histologic subtypes. METHODS: We conducted a nested case-control study within the Kaiser Permanente Northern California (KPNC) health care network, and meta-analysis combining our results with those of previously published studies. Our KPNC study included 685 RCC cases [421 clear cell; 65 papillary; 24 chromophobe; 35 other; 141 not otherwise specified (NOS)] and 4266 controls. Subtype-specific odds ratios (ORs) and 95% confidence intervals (CIs) for categories of body mass index (BMI) and were computed from the case-control data using polytomous logistic regression. Findings from this and other relevant studies were combined by meta-analysis using a random effects model. RESULTS: In the KPNC study, obesity (BMI ≥ 30 kg/m2) was associated with clear cell RCC (OR 1.5, 95% CI 1.1-2.1) and chromophobe RCC (OR 2.5, 95%CI 0.8-8.1), but not with papillary RCC (OR 1.0, 95% CI 0.5-1.9). In meta-analysis including three additional studies, a similar pattern of summary relative risks (SRR) for obesity was observed across subtypes (clear cell: SRR 1.8, 95% CI 1.5-2.2; chromophobe: SRR 2.2, 95% CI 1.3-3.7; papillary, SRR 1.2, 95% CI 0.8-1.6). CONCLUSIONS: These findings support the hypothesis that histologic subtypes of RCC possess distinct etiologic pathways, with obesity important for the development of clear cell and, possibly, chromophobe RCC, but not papillary RCC. Published by Elsevier Ltd.
Entities:
Keywords:
Body mass index; Case-control studies; Histology; Meta-analysis; Renal cell carcinoma
Authors: Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton Journal: Cancer Cell Date: 2014-08-21 Impact factor: 31.743
Authors: Alexander Sankin; Jacob Cohen; Hongbei Wang; Richard J Macchia; Nicholas Karanikolas Journal: Int Braz J Urol Date: 2011 Jan-Feb Impact factor: 1.541
Authors: Kirk A Keegan; Clayton W Schupp; Karim Chamie; Nicholas J Hellenthal; Christopher P Evans; Theresa M Koppie Journal: J Urol Date: 2012-06-13 Impact factor: 7.450
Authors: Tuo Deng; Christopher J Lyon; Stephen Bergin; Michael A Caligiuri; Willa A Hsueh Journal: Annu Rev Pathol Date: 2016-05-23 Impact factor: 23.472
Authors: Sandra Steffens; Kristina I Ringe; Katharina Schroeer; Rieke Lehmann; Julia Rustemeier; Gerd Wegener; Mark Schrader; Rainer Hofmann; Markus A Kuczyk; Andres J Schrader Journal: Int J Urol Date: 2012-11-26 Impact factor: 3.369
Authors: A Ari Hakimi; Helena Furberg; Emily C Zabor; Anders Jacobsen; Nikolaus Schultz; Giovanni Ciriello; Nina Mikklineni; Brandon Fiegoli; Philip H Kim; Martin H Voss; Hui Shen; Peter W Laird; Chris Sander; Victor E Reuter; Robert J Motzer; James J Hsieh; Paul Russo Journal: J Natl Cancer Inst Date: 2013-11-27 Impact factor: 13.506
Authors: Catherine L Callahan; Kendra Schwartz; Douglas A Corley; Julie J Ruterbusch; Wei K Zhao; Brian Shuch; Barry I Graubard; Nathaniel Rothman; Wong-Ho Chow; Debra T Silverman; Mark P Purdue; Jonathan N Hofmann Journal: Cancer Causes Control Date: 2019-11-28 Impact factor: 2.506
Authors: Jeroen A A van de Pol; Lisa George; Piet A van den Brandt; Marcella M L L Baldewijns; Leo J Schouten Journal: Int J Cancer Date: 2020-07-13 Impact factor: 7.396